180 related articles for article (PubMed ID: 28677791)
1. miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
Huang YQ; Ling XH; Yuan RQ; Chen ZY; Yang SB; Huang HX; Zhong WD; Qiu SP
Mol Med Rep; 2017 Sep; 16(3):2431-2438. PubMed ID: 28677791
[TBL] [Abstract][Full Text] [Related]
2. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
Wang Y; Pei X; Xu P; Tan Z; Zhu Z; Zhang G; Jiang Z; Deng Z
Oncol Rep; 2020 Sep; 44(3):849-862. PubMed ID: 32582990
[TBL] [Abstract][Full Text] [Related]
3. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
Verduci L; Simili M; Rizzo M; Mercatanti A; Evangelista M; Mariani L; Rainaldi G; Pitto L
J Biol Chem; 2010 Dec; 285(50):39551-63. PubMed ID: 20923760
[TBL] [Abstract][Full Text] [Related]
5. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF.
Wang J; Su L; Chen X; Li P; Cai Q; Yu B; Liu B; Wu W; Zhu Z
Biomed Pharmacother; 2014 Jun; 68(5):557-64. PubMed ID: 24857172
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Ling XH; Han ZD; Xia D; He HC; Jiang FN; Lin ZY; Fu X; Deng YH; Dai QS; Cai C; Chen JH; Liang YX; Zhong WD; Wu CL
Mol Biol Rep; 2014 May; 41(5):2779-88. PubMed ID: 24452717
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
[TBL] [Abstract][Full Text] [Related]
9. A splicing-independent function of SF2/ASF in microRNA processing.
Wu H; Sun S; Tu K; Gao Y; Xie B; Krainer AR; Zhu J
Mol Cell; 2010 Apr; 38(1):67-77. PubMed ID: 20385090
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
11. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.
Sun S; Zhang Z; Sinha R; Karni R; Krainer AR
Nat Struct Mol Biol; 2010 Mar; 17(3):306-12. PubMed ID: 20139984
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle.
Xiong Z; Shaibani A; Li YP; Yan Y; Zhang S; Yang Y; Yang F; Wang H; Yang XF
J Clin Pathol; 2006 Aug; 59(8):855-61. PubMed ID: 16574722
[TBL] [Abstract][Full Text] [Related]
13. JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.
Uleri E; Ibba G; Piu C; Caocci M; Leoni S; Arru G; Serra C; Sechi G; Dolei A
J Neurovirol; 2017 Apr; 23(2):226-238. PubMed ID: 27812788
[TBL] [Abstract][Full Text] [Related]
14. Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.
Sinha R; Allemand E; Zhang Z; Karni R; Myers MP; Krainer AR
Mol Cell Biol; 2010 Jun; 30(11):2762-74. PubMed ID: 20308322
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
17. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.
Yin W; Chen J; Wang G; Zhang D
Mol Med Rep; 2019 Aug; 20(2):951-958. PubMed ID: 31173237
[TBL] [Abstract][Full Text] [Related]
20. The splicing-factor oncoprotein SF2/ASF activates mTORC1.
Karni R; Hippo Y; Lowe SW; Krainer AR
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15323-7. PubMed ID: 18832178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
